1-6 of 6
Satoshi Nagata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma

Available to Purchase
Masanori Onda, Satoshi Nagata, Mitchell Ho, Tapan K. Bera, Raffit Hassan, Richard H. Alexander, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4225–4231.
https://doi.org/10.1158/1078-0432.CCR-06-0472
Published: 20 July 2006
View articletitled, Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma
Open the PDF for Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma in another window
Journal Articles

New Monoclonal Antibodies to Mesothelin Useful for Immunohistochemistry, Fluorescence-Activated Cell Sorting, Western Blotting, and ELISA

Available to Purchase
Masanori Onda, Mark Willingham, Satoshi Nagata, Tapan K. Bera, Richard Beers, Mitchell Ho, Raffit Hassan, Robert J. Kreitman, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5840–5846.
https://doi.org/10.1158/1078-0432.CCR-05-0578
Published: 22 August 2005
View articletitled, New Monoclonal Antibodies to Mesothelin Useful for Immunohistochemistry, Fluorescence-Activated Cell Sorting, Western Blotting, and ELISA
Open the PDF for New Monoclonal Antibodies to Mesothelin Useful for Immunohistochemistry, Fluorescence-Activated Cell Sorting, Western Blotting, and ELISA in another window
Journal Articles

HA22 (R490A) Is a Recombinant Immunotoxin with Increased Antitumor Activity without an Increase in Animal Toxicity

Available to Purchase
SookHee Bang, Satoshi Nagata, Masanori Onda, Robert J. Kreitman, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1545–1550.
https://doi.org/10.1158/1078-0432.CCR-04-1939
Published: 02 March 2005
View articletitled, HA22 (R490A) Is a Recombinant Immunotoxin with Increased Antitumor Activity without an Increase in Animal Toxicity
Open the PDF for HA22 (R490A) Is a Recombinant Immunotoxin with Increased Antitumor Activity without an Increase in Animal Toxicity in another window
Journal Articles

Immunoglobulin Superfamily Receptor Translocation Associated 2 Protein on Lymphoma Cell Lines and Hairy Cell Leukemia Cells Detected by Novel Monoclonal Antibodies

Available to Purchase
Tomoko Ise, Hiroshi Maeda, Kenneth Santora, Laiman Xiang, Robert J. Kreitman, Ira Pastan, Satoshi Nagata
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 87–96.
https://doi.org/10.1158/1078-0432.87.11.1
Published: 21 January 2005
View articletitled, Immunoglobulin Superfamily Receptor Translocation Associated 2 Protein on Lymphoma Cell Lines and Hairy Cell Leukemia Cells Detected by Novel Monoclonal Antibodies
Open the PDF for Immunoglobulin Superfamily Receptor Translocation Associated 2 Protein on Lymphoma Cell Lines and Hairy Cell Leukemia Cells Detected by Novel Monoclonal Antibodies in another window
Journal Articles

Functionalization of Tumor Necrosis Factor-α Using Phage Display Technique and PEGylation Improves Its Antitumor Therapeutic Window

Available to Purchase
Hiroko Shibata, Yasuo Yoshioka, Shinji Ikemizu, Kyoko Kobayashi, Yoko Yamamoto, Yohei Mukai, Takayuki Okamoto, Madoka Taniai, Maki Kawamura, Yasuhiro Abe, Shinsaku Nakagawa, Takao Hayakawa, Satoshi Nagata, Yuriko Yamagata, Tadanori Mayumi, Haruhiko Kamada, Yasuo Tsutsumi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8293–8300.
https://doi.org/10.1158/1078-0432.CCR-04-0770
Published: 28 December 2004
View articletitled, Functionalization of Tumor Necrosis Factor-α Using Phage Display Technique and PEGylation Improves Its Antitumor Therapeutic Window
Open the PDF for Functionalization of Tumor Necrosis Factor-α Using Phage Display Technique and PEGylation Improves Its Antitumor Therapeutic Window in another window
Journal Articles

Novel Anti-CD30 Recombinant Immunotoxins Containing Disulfide-stabilized Fv Fragments

Available to Purchase
Satoshi Nagata, Masanori Onda, Yoshito Numata, Kenneth Santora, Richard Beers, Robert J. Kreitman, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2345–2355.
Published: 01 July 2002
View articletitled, Novel Anti-CD30 Recombinant Immunotoxins Containing Disulfide-stabilized Fv Fragments
Open the PDF for Novel Anti-CD30 Recombinant Immunotoxins Containing Disulfide-stabilized Fv Fragments in another window